Financhill
Back

AIM ImmunoTech 10K Form

Sell
37

AIMI
AIM ImmunoTech

Last Price:
$0.09
Seasonality Move:
-3.71%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AIMI News And Ratings

See the #1 stock for the next 7 days that we like better than AIMI

AIMI Financial Statistics

Sales & Book Value

Annual Sales: $170K
Cash Flow: $-2.4M
Price / Cash Flow: 0
Annual Sales: $-0.05
Price / Book: 0

Profitability

EPS (TTM): -0.24000
Net Income (TTM): $-15.2M
Gross Margin: $139K
Return on Equity: -877.96%
Return on Assets: -126%

AIM ImmunoTech Earnings Forecast

Key AIM ImmunoTech Financial Ratios

  • The Gross Profit Margin over the past 30 years for AIMI is 81.76%.
  • The Selling, General & Administrative Expenses for AIMI have been equal to 8,067.06% of Gross Profit Margin.
  • The Research & Development expenses have been 3,645.29% of Revenue.
  • The Net Earning history of AIMI is -10,188.24% of Total Revenues.
  • Per Share Earnings over the last 30 years have been positive in 18 years.

AIM ImmunoTech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: AIMI
Website: aimimmuno.com

Debt

Debt-to-Equity Ratio: -0.51
Current Ratio: 0.26
Quick Ratio: 0.23

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AIMI Technical Analysis vs Fundamental Analysis

Sell
37
AIM ImmunoTech (AIMI) is a Sell

Is AIM ImmunoTech a Buy or a Sell?

  • AIM ImmunoTech stock is rated a Sell
    The current AIM ImmunoTech [AIMI] share price is $0.09. The Score for AIMI is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.